- Report
- October 2025
- 195 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- April 2025
- 200 Pages
Global
From €4038EUR$4,490USD£3,557GBP
- Report
- November 2025
- 159 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- August 2025
- 194 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 181 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- August 2025
- 188 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- August 2025
- 183 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- September 2025
- 250 Pages
Global
From €4038EUR$4,490USD£3,557GBP
- Report
- September 2025
- 250 Pages
Global
From €4038EUR$4,490USD£3,557GBP
- Report
- September 2025
- 250 Pages
Global
From €4038EUR$4,490USD£3,557GBP
- Report
- November 2025
- 381 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 194 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €899EUR$1,000USD£792GBP
€1124EUR$1,250USD£990GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1439EUR$1,600USD£1,268GBP
€1799EUR$2,000USD£1,584GBP
- Drug Pipelines
- April 2025
- 100 Pages
Global
From €1439EUR$1,600USD£1,268GBP
€1799EUR$2,000USD£1,584GBP
- Report
- June 2025
- 150 Pages
Global
From €2427EUR$2,699USD£2,138GBP
- Report
- July 2025
- 215 Pages
Global
From €4492EUR$4,995USD£3,957GBP
- Report
- June 2024
- 200 Pages
Global
From €5720EUR$6,360USD£5,038GBP
€7150EUR$7,950USD£6,298GBP
- Report
- November 2023
- 30 Pages
Global
From €1979EUR$2,200USD£1,743GBP
€2473EUR$2,750USD£2,179GBP
- Report
- November 2023
- 30 Pages
Global
From €1979EUR$2,200USD£1,743GBP
€2473EUR$2,750USD£2,179GBP

Vancomycin is an antibiotic used to treat a wide range of bacterial infections. It is a glycopeptide antibiotic, derived from the bacterium Amycolatopsis orientalis, and is used to treat infections caused by Gram-positive bacteria. Vancomycin is often used as a last-resort antibiotic, when other antibiotics have failed to treat an infection. It is also used to treat infections caused by Clostridium difficile, a bacterium that can cause severe diarrhea.
Vancomycin is available in both oral and intravenous forms, and is used to treat a variety of infections, including skin and soft tissue infections, bone and joint infections, and endocarditis. It is also used to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
Vancomycin is a widely used antibiotic, and is available from a number of pharmaceutical companies, including Pfizer, Merck, and AstraZeneca. It is also available in generic form from a number of generic drug manufacturers. Show Less Read more